318 related articles for article (PubMed ID: 23182711)
21. Expression of Fc alpha/mu receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathy.
McDonald KJ; Cameron AJ; Allen JM; Jardine AG
Biochem Biophys Res Commun; 2002 Jan; 290(1):438-42. PubMed ID: 11779189
[TBL] [Abstract][Full Text] [Related]
22. Chicken IgY binds its receptor at the CH3/CH4 interface similarly as the human IgA: Fc alpha RI interaction.
Pürzel J; Schmitt R; Viertlboeck BC; Göbel TW
J Immunol; 2009 Oct; 183(7):4554-9. PubMed ID: 19748988
[TBL] [Abstract][Full Text] [Related]
23. A human immunoglobulin (Ig)A calpha3 domain motif directs polymeric Ig receptor-mediated secretion.
Hexham JM; White KD; Carayannopoulos LN; Mandecki W; Brisette R; Yang YS; Capra JD
J Exp Med; 1999 Feb; 189(4):747-52. PubMed ID: 9989991
[TBL] [Abstract][Full Text] [Related]
24. Immunoglobulin-binding sites of human FcalphaRI (CD89) and bovine Fcgamma2R are located in their membrane-distal extracellular domains.
Morton HC; van Zandbergen G; van Kooten C; Howard CJ; van de Winkel JG; Brandtzaeg P
J Exp Med; 1999 Jun; 189(11):1715-22. PubMed ID: 10359575
[TBL] [Abstract][Full Text] [Related]
25. The IgA/IgM receptor expressed on a murine B cell lymphoma is poly-Ig receptor.
Phillips-Quagliata JM; Patel S; Han JK; Arakelov S; Rao TD; Shulman MJ; Fazel S; Corley RB; Everett M; Klein MH; Underdown BJ; Corthésy B
J Immunol; 2000 Sep; 165(5):2544-55. PubMed ID: 10946281
[TBL] [Abstract][Full Text] [Related]
26. A conserved binding site on the receptor for polymeric Ig is homologous to CDR1 of Ig V kappa domains.
Bakos MA; Kurosky A; Czerwinski EW; Goldblum RM
J Immunol; 1993 Aug; 151(3):1346-52. PubMed ID: 8335931
[TBL] [Abstract][Full Text] [Related]
27. Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human fcalpha receptor (FcalphaR) CD89.
Pleass RJ; Dunlop JI; Anderson CM; Woof JM
J Biol Chem; 1999 Aug; 274(33):23508-14. PubMed ID: 10438530
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of the dimer formation of Fcα/μ receptor (CD351).
Takagaki K; Satoh K; Honda S; Shibuya A
Mol Immunol; 2013 Nov; 56(1-2):23-7. PubMed ID: 23665380
[TBL] [Abstract][Full Text] [Related]
29. Molecular and functional characteristics of the Fcalpha/muR, a novel Fc receptor for IgM and IgA.
Shibuya A; Honda S
Springer Semin Immunopathol; 2006 Dec; 28(4):377-82. PubMed ID: 17061088
[TBL] [Abstract][Full Text] [Related]
30. The carboxyl-terminal domains of IgA and IgM direct isotype-specific polymerization and interaction with the polymeric immunoglobulin receptor.
Braathen R; Sorensen V; Brandtzaeg P; Sandlie I; Johansen FE
J Biol Chem; 2002 Nov; 277(45):42755-62. PubMed ID: 12213814
[TBL] [Abstract][Full Text] [Related]
31. Expression of monovalent fragments derived from a human IgM autoantibody in E. coli. The input of the somatically mutated CDR1/CDR2 and of the CDR3 into antigen binding specificity.
Jahn S; Roggenbuck D; Niemann B; Ward ES
Immunobiology; 1995 Aug; 193(5):400-19. PubMed ID: 8522357
[TBL] [Abstract][Full Text] [Related]
32. Domain deletions in the human polymeric Ig receptor disclose differences between its dimeric IgA and pentameric IgM interaction.
Norderhaug IN; Johansen FE; Krajci P; Brandtzaeg P
Eur J Immunol; 1999 Oct; 29(10):3401-9. PubMed ID: 10540352
[TBL] [Abstract][Full Text] [Related]
33. Site-directed in vitro immunization leads to a complete human monoclonal IgG4 lambda that binds specifically to the CDR2 region of CTLA-4 (CD152) without interfering the engagement of natural ligands.
Chin LT; Chu C; Chen HM; Hsu SC; Weng BC; Chu CH
BMC Biotechnol; 2007 Aug; 7():51. PubMed ID: 17714596
[TBL] [Abstract][Full Text] [Related]
34. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
[TBL] [Abstract][Full Text] [Related]
35. Shark IgNAR antibody mimotopes target a murine immunoglobulin through extended CDR3 loop structures.
Simmons DP; Streltsov VA; Dolezal O; Hudson PJ; Coley AM; Foley M; Proll DF; Nuttall SD
Proteins; 2008 Apr; 71(1):119-30. PubMed ID: 17932913
[TBL] [Abstract][Full Text] [Related]
36. Crystal structure of a T cell receptor Valpha11 (AV11S5) domain: new canonical forms for the first and second complementarity determining regions.
Machius M; Cianga P; Deisenhofer J; Ward ES
J Mol Biol; 2001 Jul; 310(4):689-98. PubMed ID: 11453680
[TBL] [Abstract][Full Text] [Related]
37. Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells.
Leung JCK; Tsang AWL; Chan DTM; Lai KN
J Am Soc Nephrol; 2000 Feb; 11(2):241-249. PubMed ID: 10665931
[TBL] [Abstract][Full Text] [Related]
38. Transfer of putative complementarity-determining region loops of T cell receptor V domains confers toxin reactivity but not peptide/MHC specificity.
Patten PA; Rock EP; Sonoda T; Fazekas de St Groth B; Jorgensen JL; Davis MM
J Immunol; 1993 Mar; 150(6):2281-94. PubMed ID: 7680688
[TBL] [Abstract][Full Text] [Related]
39. Analysis of polymeric immunoglobulin receptor- and CD300-like molecules from Atlantic salmon.
Tadiso TM; Sharma A; Hordvik I
Mol Immunol; 2011 Dec; 49(3):462-73. PubMed ID: 22001425
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the Fc mu receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects.
Pricop L; Rabinowich H; Morel PA; Sulica A; Whiteside TL; Herberman RB
J Immunol; 1993 Sep; 151(6):3018-29. PubMed ID: 7690792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
